⌘K

Login Start Free

Home/Filings/4/0001209191-22-053004

4//SEC Filing

Gaspar Bobby 4

Accession 0001209191-22-053004

CIK 0001748907other

View on SEC.gov Company Profile

Filed

Oct 5, 8:00 PM ET

Accepted

Oct 6, 6:11 PM ET

Size

27.3 KB

Accession

0001209191-22-053004

Insider Transaction Report

Form 4

Period: 2022-10-04

Orchard Therapeutics plcORTX

DirectorSee Remarks

Transactions

Award
Stock Option (Right to Buy)
2022-10-04+200,000→ 200,000 total
Exercise: $0.58Exp: 2030-01-01→ Ordinary Shares (200,000 underlying)
Award
Stock Option (Right to Buy)
2022-10-04+300,000→ 300,000 total
Exercise: $0.58Exp: 2030-03-31→ Ordinary Shares (300,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2022-10-04−850,000→ 0 total
Exercise: $5.98Exp: 2031-01-31→ Ordinary Shares (850,000 underlying)
Award
Stock Option (Right to Buy)
2022-10-04+850,000→ 850,000 total
Exercise: $0.58Exp: 2031-01-31→ Ordinary Shares (850,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2022-10-04−55,006→ 0 total
Exercise: $5.98Exp: 2031-01-31→ Ordinary Shares (55,006 underlying)
Award
Stock Option (Right to Buy)
2022-10-04+55,006→ 55,006 total
Exercise: $0.58Exp: 2031-01-31→ Ordinary Shares (55,006 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2022-10-04−50,000→ 0 total
Exercise: $12.54Exp: 2029-01-15→ Ordinary Shares (50,000 underlying)
Award
Stock Option (Right to Buy)
2022-10-04+50,000→ 50,000 total
Exercise: $0.58Exp: 2029-01-15→ Ordinary Shares (50,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2022-10-04−200,000→ 0 total
Exercise: $13.58Exp: 2030-01-01→ Ordinary Shares (200,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2022-10-04−300,000→ 0 total
Exercise: $7.05Exp: 2030-03-31→ Ordinary Shares (300,000 underlying)

Footnotes (7)

[F1]On October 4, 2022, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.
[F2]The shares subject to this option vest in equal monthly installments over the four years after January 16, 2019.
[F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
[F4]The shares subject to this option vest in equal monthly installments over the four years after January 2, 2020.
[F5]The shares subject to this option vest in equal monthly installments over the four years after April 1, 2020.
[F6]The shares subject to this option vest in equal monthly installments over the four years after February 1, 2021.
[F7]The shares subject to this option are fully vested as of the date hereof.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Orchard Therapeutics plc

CIK 0001748907

Entity typeother

Related Parties

1

filerCIK 0001793992

Filing Metadata

Form type: 4
Filed: Oct 5, 8:00 PM ET
Accepted: Oct 6, 6:11 PM ET
Size: 27.3 KB

View on SEC.gov